trending Market Intelligence /marketintelligence/en/news-insights/trending/inxcaq6zfkguqoet4vhcqq2 content esgSubNav
In This List

IMV names director

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


IMV names director

IMV Inc. appointed Julia Gregory as a board member.

Gregory recently served as CEO and director of ContraFect Corp., a public biotechnology company developing anti-infectives.

Nova Scotia-based IMV is a clinical-stage company that, with its subsidiaries, develops products based on its platform and products with a primary focus on T-cell activating therapies for cancer.